A Phase IIb Pilot Study to Assess the Efficacy, Safety and Pharmacodynamics Effects of Pembrolizumab and BL-8040 in Patients With Metastatic Pancreatic Cancer
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs BL 8040 (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 18 Jan 2018 Trial design presented at the 2018 Gastrointestinal Cancers Symposium.
- 02 Dec 2016 Status changed from not yet recruiting to recruiting.
- 15 Sep 2016 Status changed from planning to not yet recruiting.